SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-23-015762
Filing Date
2023-04-28
Accepted
2023-04-28 16:04:42
Documents
6
Period of Report
2023-06-08

Document Format Files

Seq Description Document Type Size
1 DEF 14A proxy_-_def_14a.htm DEF 14A 1648359
2 GRAPHIC img182068417_0.jpg GRAPHIC 6391
3 GRAPHIC img182068417_1.jpg GRAPHIC 28498
4 GRAPHIC img182068417_2.jpg GRAPHIC 27861
5 GRAPHIC img182068417_3.jpg GRAPHIC 533687
6 GRAPHIC img182068417_4.jpg GRAPHIC 457204
  Complete submission text file 0000950170-23-015762.txt   3099417
Mailing Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 650-392-8412
SUTRO BIOPHARMA, INC. (Filer) CIK: 0001382101 (see all company filings)

IRS No.: 452441988 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38662 | Film No.: 23865831
SIC: 2836 Biological Products, (No Diagnostic Substances)